Research has shown that alterations in NBS1 are implicated in several types of cancer, including breast cancer, ovarian cancer, and prostate cancer. In particular, overexpression or amplification of NBS1 has been observed in a variety of tumors, suggesting its role in tumorigenesis. Additionally, NBS1 polymorphisms have been associated with an increased risk of developing certain cancers.
